Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ma-Chao Li, Yao Wang, Hong Zhang, Yong Liu, Xue-Jun Chen, Hong-Wei Yang, Ping Ma, Ding-Cheng Wang, Bing-Chang Zhang, Ai-Ying Dong, Chun-Xin Wang, Yan Li, Peng Bai, Wen-Min Tang, Jue Wang, Zhu-Jun Shao & Ying-Chun Xu. (2021) Serotype distribution and clinical characteristics associated with streptococcus pneumoniae among Chinese children and adults with invasive pneumococcal disease: a multicenter observational study. Human Vaccines & Immunotherapeutics 17:1, pages 146-156.
Read now
Read now
Lili Huang, Ling Wang, Hong Li, Yuansheng Hu, Weiping Ru, Weixiao Han, Gang Shi, Qiang Ye, Zhen Han, Jielai Xia, Shengli Xia, Miao Xu & Jing Li. (2019) A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly. Human Vaccines & Immunotherapeutics 15:1, pages 249-255.
Read now
Read now
Mingjuan Yin, Lingfeng Huang, Yan Zhang, Na Yu, Xiaojia Xu, Yaping Liang & Jindong Ni. (2018) Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis. Expert Review of Vaccines 17:7, pages 653-663.
Read now
Read now
Yang Wang, Jingxin Li, Yuxiao Wang, Wei Gu & Fengcai Zhu. (2018) Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations. Human Vaccines & Immunotherapeutics 14:4, pages 1003-1012.
Read now
Read now
Qi Liang, Gui-Fan Li & Feng-Cai Zhu. (2016) Vaccine profile of PPV23: Beijing Minhai Biotech 23-valent pneumococcal vaccine. Expert Review of Vaccines 15:11, pages 1351-1359.
Read now
Read now
Articles from other publishers (7)
Jia Guo, Haijun Zhang, Haonan Zhang, Xiaozhen Lai, Jiahao Wang, Huangyufei Feng & Hai Fang. (2023) Cost-effectiveness of pneumococcal vaccines among adults aged 65 years and older in China: A comparative study. Vaccine 41:3, pages 716-723.
Crossref
Crossref
Sergio E. Chiarella, Sarah M. Jenkins, Miguel A. Park, Roshini S. Abraham & Avni Y. Joshi. (2021) Sex differences in antibody responses to the 23-valent pneumococcal polysaccharide vaccination. Annals of Allergy, Asthma & Immunology 127:4, pages 509-510.
Crossref
Crossref
Xiaodong Sun, Yuekun Tang, Xiaoying Ma, Xiang Guo, Zhuoying Huang, Jia Ren, Jing Qiu, Hongli Jiang & Yihan Lu. (2021) Cost-Effectiveness Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine Program for the Elderly Aged 60 Years or Older in Shanghai, China. Frontiers in Public Health 9.
Crossref
Crossref
Kwan Soo Kim, In-Sun Oh, Hyun Jeong Kim, Inmyung Song, Min Soo Park & Ju-Young Shin. (2020) Signal Detection of Adverse Events Following Pneumococcal Vaccines from the Korea Adverse Event Reporting System Database, 2005–2016. Yonsei Medical Journal 61:3, pages 243.
Crossref
Crossref
Annefleur C. Langedijk, Mariëlle van Aalst, Bob Meek, Ester M.M. van Leeuwen, Sacha Zeerleder, Ellen Meijer, Mette D. Hazenberg, Martin P. Grobusch & Abraham Goorhuis. (2019) Long-term pneumococcal vaccine immunogenicity following allogeneic hematopoietic stem cell transplantation. Vaccine 37:3, pages 510-515.
Crossref
Crossref
Daijun Zhao, Ruoyan Gai Tobe, Min Cui, Jinchun He & Bin Wu. (2016) Cost-effectiveness of a 23-valent pneumococcal polysaccharide vaccine immunization programme for the elderly in Shanghai, China. Vaccine 34:50, pages 6158-6165.
Crossref
Crossref
Xiuting Mo, Ruoyan Gai Tobe, Xiaoyan Liu & Rintaro Mori. (2016) Cost-effectiveness and Health Benefits of Pediatric 23-valent Pneumococcal Polysaccharide Vaccine, 7-valent Pneumococcal Conjugate Vaccine and Forecasting 13-valent Pneumococcal Conjugate Vaccine in China. Pediatric Infectious Disease Journal 35:11, pages e353-e361.
Crossref
Crossref